Andere talen Organogenesis Holdings Inc.

Aandelen

ORGO

US68621F1021

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,86 ^USD	+2,51%		-4,67%	-30,07%

29/02	Transcript : Organogenesis Holdings Inc., Q4 2023 Earnings Call, Feb 29, 2024
29/02	Organogenesis Holdings Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024	16/04
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case	03/04
Organogenesis: Q4 Earnings Snapshot	29/02
Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q4 Revenue $99.7M, vs. Street Est of $109.1M	29/02
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance	29/02
Organogenesis Holdings Inc. Provides Earnings Guidance for the First Quarter and for the Year Ending December 31, 2024	29/02
Organogenesis Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference	12/02
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024	08/02
Organogenesis Holdings Insider Sold Shares Worth $940,860, According to a Recent SEC Filing	11/01
HippoFi Hires World's Top Regenerative Therapy Expert, Dr. Gail Naughton, to Drive Commercialization Plans of its Proprietary Technologies	12/12
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	07/12
Organogenesis: Q3 Earnings Snapshot	09/11
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q3 Revenue $108.5M, vs. Street Est of $111.4M	09/11
Organogenesis Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results	09/11
Organogenesis Holdings Inc. Provides Earnings Guidance for the Year Ending December 31, 2023	09/11
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023	05-10-23
Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS	28-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Organogenesis Holdings Inc.

Aandelen

ORGO

US68621F1021

Andere talen

Filters